$22.74
+2.74 (+13.70%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+1.93%
1Y
-23.56%
YTD
-15.72%
Open$20.70
Previous Close$20.00
Day High$22.77
Day Low$20.12
52W High$42.50
52W Low$14.19
Volume—
Avg Volume5.35M
Market Cap5.65B
P/E Ratio166.37
EPS$0.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.57
Below
RSI (14)
21.6
Oversold
Analyst Ratings
Strong Buy
16 analysts
Price Target
+36.0% upside
Current
$22.74
$22.74
Target
$30.92
$30.92
$20.23
$30.92 avg
$48.05
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.21B | 1.64B | 1.52B |
| Net Income | -101,237,983 | 316.28M | 306.08M |
| Profit Margin | -8.4% | 19.3% | 20.1% |
| EBITDA | 37.62M | 415.16M | 429.14M |
| Free Cash Flow | — | 185.08M | 215.40M |
| Rev Growth | — | +14.2% | +10.8% |
| Debt/Equity | 0.66 | 0.26 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |